Slow and steady wins the race: Practical (and philosophical) considerations of treatment activity evaluation when novel anticancer agents just slow neoplastic progression

Camillo Porta, Alessandro Vercelli, Chiara Paglino

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)721-722
Number of pages2
JournalEuropean Urology
Issue number4
Publication statusPublished - Apr 2014

ASJC Scopus subject areas

  • Urology

Cite this